Marketscreener, stock market website
31a276c35f6365bf92e4.k58sT7I_fTo0jV14x3KbkZLa2h10CfAxOaKpB7RgHGo.3_gZfoJLFQ1w2Tsd8UGtx8WrtCk-TpF6VPPiYts5clnC-xV700w7dEXXbQ

Log In

Forgot your password ?
Or log in with
GoogleGoogle

Email Registration
Or log in with
GoogleGoogle
Log In

Forgot your password ?
Not a member ?
Email Registration
Or log in with
GoogleGoogle
  • Markets
    Equities
    Top Capitalization
    Australia
    North America
    Europe
    Asia
    Middle East
    Sector Research
    Company calendar
    Equities Analysis
    Most popular
    LINDSELL TRAIN INVESTMENT TRUST PLC
    NVIDIA CORPORATION
    TESLA, INC.
    NEWAY VALVE (SUZHOU) CO., LTD.
    AIRBUS SE
    MICROSOFT CORPORATION
    NOVO NORDISK A/S
    Indices
    Homepage
    Rankings
    Europe
    America
    Asia
    Africa
    Index Analysis
    Indexes News
    SYDNEY ASX
    S&P 500
    NASDAQ 100
    DOW JONES
    FTSE 100
    EURO STOXX 50
    TSX COMP
    HANG SENG
    Currency / Forex
    Homepage
    Rankings
    Currency Cross Rate
    Currency Converter
    Forex Analysis
    Currencies News
    AUD / USD
    AUD/CNY
    AUD/JPY
    AUD/EUR
    AUD/SGD
    Commodities
    Homepage
    Energy
    Precious metals
    Agriculture
    Industrial Metals
    Livestock and Cattle
    GOLD
    CRUDE OIL (WTI)
    CRUDE OIL (BRENT)
    SILVER
    PLATINUM
    Cryptocurrencies
    Homepage
    Rankings
    Charts
    Analysis
    News
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    Interest Rates
    Homepage
    Yield Curve
    Developed Nations
    Emerging Countries
    ETF
    Summary
    Screener
    Analysis
    News
  • News
    All News
    World
    Australia
    Europe
    North America
    South America
    Asia
    Africa
    Middle East
    Emerging
    Companies
    All News
    Analyst Reco.
    Rumors
    IPOs
    Capital Markets Transactions
    New Contracts
    Profit Warnings
    Appointments
    Press Releases
    Security Transactions
    Earnings reports
    New markets
    New products
    Corporate strategies
    Legal risks
    Share buybacks
    Mergers and acquisitions
    Call Transcripts
    Guidance
    Indices
    Currency / Forex
    Commodities
    Cryptocurrencies
    ETF
    Interest Rates
    Economy
    Themes
    Asset Management
    Activism
    Climate and ESG
    Cybersecurity
    Geopolitics
    Central Banks
    Inflation
    Business Leaders
    Sectors
    Calendar
    Economic Calendar
    Company calendar
    All our articles
    Most Read News
    Hot News
  • Analysis
    All Analysis
    Must Read
    Equities
    Interviews
    Indices
    Currencies
    Commodities
    ETF
    Cryptocurrencies
    Stock Trading Strategies
    All
    America
    Europe
    Asia
  • Our Shows
    Shows
    Must Watch
    Satirical Cartoon
    Today's Editorial
    Crypto Recap
  • Stock Picks
    All our investments
    United States
    Europe
    Asia, Pacific
  • Portfolios
    Virtual Portfolios
    European Portfolio
    USA Portfolio
    Asian Portfolio
  • Watchlists
    My Watchlists
    Watchlists
    My previous session
    My most visited
    Most popular
    Investment Style
    Homepage
    Multibaggers
    Trend-Following Stocks
    Quality stocks
    Low capital intensity
    Monthly dividends
    Momentum stocks
    Investment Themes
    Homepage
    In Vino Veritas
    Semiconductors
    Solar energy
    3D Printing
    Adtechs
    The Vegan Market
  • Rankings
    Top Movers
    Short-Term Gainers & Losers
    Long-term Gainers & Losers
    Unusual volumes
    New Historical Highs
    New Historical Lows
    Top Fundamentals
    Fundamental Composite
    Sales growth
    Earnings Growth
    Profitability
    Finances
    Rankings Valuation
    Valuation Composite
    Capitalization
    P/E ratio
    Enterprise value
    Yield
    Price to Book (PBR)
    Free Cash Flow (FCF)
    Top Consensus
    Consensus composite
    Analyst Opinion
    Target price
    Opinion Divergences
    Estimates Revisions
    Analyst coverage
    Technical Analysis Rankings
    RSI
    GAPS
    STIM
    Daily Breakouts
    Weekly Breakouts
    Trends
    Volatility
    Top ranking ESG
    ESG MSCI
    Environment
    Social
    Governance
    Islamic Finance
    Paris Agreement
  • Screeners
    Stock Screener Home
    Investment Themes
    Cannibal companies
    Pets
    Moat
    Semiconductors
    Artificial Intelligence
    The genomic revolution
    Technical Rankings
    Oversold stocks
    Overbought stocks
    Close to resistance
    Close to support
    Accumulation Phases
    Most volatile stocks
    Fundamental Rankings
    Top Investor Rating
    Top Trading Rating
    Top Consensus
    Top Growth
    Top Dividends
    Low valuations
    My Screeners
    All my stocks
    Watchlists
    Virtual Portfolios
  • Tools
    MarketScreener tools
    Stock Screener
    iPhone app
    Expert tools
    Stock Screener PRO
    Portfolio Creator
    Event Screener
    Dynamic Chart
    Company calendar
    Economic Calendar
    Currency Converter
  • Our Services
    Our subscriptions
    Our Stock Picks
    Stock Screener
    Thematic Investment Lists
    MarketScreener Portfolios
    European Portfolio
    USA Portfolio
    Asian Portfolio
  • Homepage
  • Markets
    • Equities
      • Top Capitalization
      • Australia
      • North America
      • Europe
      • Asia
      • Middle East
      • Sector Research
      • Company calendar
      • Equities Analysis
      • Most popular
      • LINDSELL TRAIN INVESTMENT TRUST PLC
      • NVIDIA CORPORATION
      • TESLA, INC.
      • NEWAY VALVE (SUZHOU) CO., LTD.
      • AIRBUS SE
      • MICROSOFT CORPORATION
      • NOVO NORDISK A/S
    • Indices
      • Homepage
      • Rankings
      • Europe
      • America
      • Asia
      • Africa
      • Index Analysis
      • Indexes News
      • SYDNEY ASX
      • S&P 500
      • NASDAQ 100
      • DOW JONES
      • FTSE 100
      • EURO STOXX 50
      • TSX COMP
      • HANG SENG
    • Currency / Forex
      • Homepage
      • Rankings
      • Currency Cross Rate
      • Currency Converter
      • Forex Analysis
      • Currencies News
      • AUD / USD
      • AUD/CNY
      • AUD/JPY
      • AUD/EUR
      • AUD/SGD
    • Commodities
      • Homepage
      • Energy
      • Precious metals
      • Agriculture
      • Industrial Metals
      • Livestock and Cattle
      • GOLD
      • CRUDE OIL (WTI)
      • CRUDE OIL (BRENT)
      • SILVER
      • PLATINUM
    • Cryptocurrencies
      • Homepage
      • Rankings
      • Charts
      • Analysis
      • News
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    • Interest Rates
      • Homepage
      • Yield Curve
      • Developed Nations
      • Emerging Countries
    • ETF
      • Summary
      • Screener
      • Analysis
      • News
  • News
    • All News
      • World
      • Australia
      • Europe
      • North America
      • South America
      • Asia
      • Africa
      • Middle East
      • Emerging
    • Companies
      • All News
      • Analyst Reco.
      • Rumors
      • IPOs
      • Capital Markets Transactions
      • New Contracts
      • Profit Warnings
      • Appointments
      • Press Releases
      • Security Transactions
      • Earnings reports
      • New markets
      • New products
      • Corporate strategies
      • Legal risks
      • Share buybacks
      • Mergers and acquisitions
      • Call Transcripts
      • Guidance
    • Indices
    • Currency / Forex
    • Commodities
    • Cryptocurrencies
    • ETF
    • Interest Rates
    • Economy
    • Themes
      • Asset Management
      • Activism
      • Climate and ESG
      • Cybersecurity
      • Geopolitics
      • Central Banks
      • Inflation
      • Business Leaders
    • Sectors
    • Calendar
      • Economic Calendar
      • Company calendar
    • All our articles
    • Most Read News
    • Hot News
  • Analysis
    • All Analysis
    • Must Read
    • Equities
    • Interviews
    • Indices
    • Currencies
    • Commodities
    • ETF
    • Cryptocurrencies
    • Stock Trading Strategies
      • All
      • America
      • Europe
      • Asia
  • Our Shows
    • Shows
    • Must Watch
    • Satirical Cartoon
    • Today's Editorial
    • Crypto Recap
  • Stock Picks
    • All our investments
    • United States
    • Europe
    • Asia, Pacific
  • Portfolios
    • Virtual Portfolios
    • European Portfolio
    • USA Portfolio
    • Asian Portfolio
  • Watchlists
    • My Watchlists
      • Watchlists
      • My previous session
      • My most visited
      • Most popular
    • Investment Style
      • Homepage
      • Multibaggers
      • Trend-Following Stocks
      • Quality stocks
      • Low capital intensity
      • Monthly dividends
      • Momentum stocks
    • Investment Themes
      • Homepage
      • In Vino Veritas
      • Semiconductors
      • Solar energy
      • 3D Printing
      • Adtechs
      • The Vegan Market
  • Rankings
    • Top Movers
      • Short-Term Gainers & Losers
      • Long-term Gainers & Losers
      • Unusual volumes
      • New Historical Highs
      • New Historical Lows
    • Top Fundamentals
      • Fundamental Composite
      • Sales growth
      • Earnings Growth
      • Profitability
      • Finances
    • Rankings Valuation
      • Valuation Composite
      • Capitalization
      • P/E ratio
      • Enterprise value
      • Yield
      • Price to Book (PBR)
      • Free Cash Flow (FCF)
    • Top Consensus
      • Consensus composite
      • Analyst Opinion
      • Target price
      • Opinion Divergences
      • Estimates Revisions
      • Analyst coverage
    • Technical Analysis Rankings
      • RSI
      • GAPS
      • STIM
      • Daily Breakouts
      • Weekly Breakouts
      • Trends
      • Volatility
    • Top ranking ESG
      • ESG MSCI
      • Environment
      • Social
      • Governance
      • Islamic Finance
      • Paris Agreement
  • Screeners
    • Stock Screener Home
    • Investment Themes
      • Cannibal companies
      • Pets
      • Moat
      • Semiconductors
      • Artificial Intelligence
      • The genomic revolution
    • Technical Rankings
      • Oversold stocks
      • Overbought stocks
      • Close to resistance
      • Close to support
      • Accumulation Phases
      • Most volatile stocks
    • Fundamental Rankings
      • Top Investor Rating
      • Top Trading Rating
      • Top Consensus
      • Top Growth
      • Top Dividends
      • Low valuations
    • My Screeners
      • All my stocks
      • Watchlists
      • Virtual Portfolios
  • Tools
    • MarketScreener tools
      • Stock Screener
      • iPhone app
    • Expert tools
      • Stock Screener PRO
      • Portfolio Creator
      • Event Screener
    • Dynamic Chart
    • Company calendar
    • Economic Calendar
    • Currency Converter
  • Our Services
    • Our subscriptions
    • Our Stock Picks
    • Stock Screener
    • Thematic Investment Lists
    • MarketScreener Portfolios
      • European Portfolio
      • USA Portfolio
      • Asian Portfolio
Stock NOVO BNOVO NORDISK A/S
Add to a list
To use this feature you must be a member
Log inSign up

Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen
Other stock markets
01:20:00 19/06/25 am AEST
5-day change 1st Jan Change
482.50 DKK -1.13% Intraday chart for Novo Nordisk A/S -6.62% -22.70%
19/06 US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list RE
19/06 US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list RE
Summary
Quotes
Charts
Technical Analysis Static Chart Total Return chart News Chart Sector Chart Comparison Chart Relative Strength Chart
News
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
Company
Profile Governance Share ownership Group Connections
Financials
Analysts' Forecasts Income Statement Balance Sheet Cash flow Financial Ratios Business Segments
Valuation
Valuation ratios Dividend
Consensus
Analysts' Opinion Estimates Revisions
Ratings
Calendar
Sector
Sector performance Sector valuations Sector dividends Financial comparisons Sector ratings Sector consensus Sector revisions
ETFs
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Activist hedge fund Parvus builds stake in Novo Nordisk, FT reports

Published on 10/06/2025 at 04:14

Share
LockThis article is reserved for members
Unlock the article: REGISTER NOW!
100% Free Registration
Already a customer? Log In
Share
Reuters logo
© Reuters - 2025

Latest news about Novo Nordisk A/S

US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list 19/06 RE
US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list 19/06 RE
European shares fall as Middle East tensions weigh; eyes on Fed decision 19/06 RE
Scholar Rock's drug helps Zepbound patients retain more muscle in trial 19/06 RE
U.S. judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list 19/06 RE
Fat, not muscle: Drugmakers in race for next weight-loss breakthrough 19/06 RE
Health Rounds: Weight-loss surgery more effective than drugs in real world study 18/06 RE
WeightWatchers to exit process to cut $1.15 billion debt next week 18/06 RE
Mark Cuban's Cost Plus partners with telehealth firm to offer employers obesity care drugs 18/06 RE
Trump Administration to Consider Pharma Advertising Crackdown 18/06 MT
Trump Administration to Consider Pharma Advertising Crackdown, Bloomberg reports 18/06 MT
NOVO NORDISK : UBS reiterates its Buy rating 17/06 ZD
Lannebo Mixfond Offensiv increased by 2.6 percent in May – reduced exposure to cyclical industries 17/06 FW
Lilly will offer higher doses of Zepbound on its website 17/06 RE
European shares snap five-day losing streak 17/06 RE
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading 17/06 MT
Lilly to offer highest doses of weight-loss drug Zepbound on website 16/06 RE
NOVO NORDISK : Gets a Buy rating from JP Morgan 16/06 ZD
JP Morgan lowers target price for Novo Nordisk to 650 Danish kroner (1,000), reiterates overweight rating - BN 16/06 FW
Eli Lilly's experimental obesity drug shows over 11% weight loss in early trial 14/06 RE
Global markets live: Tesla, Google, Apple, Novo Nordisk, Boeing… 14/06Our Logo
Odin Norden rose 3.16 percent in May – positive reporting season for portfolio companies 13/06 FW
NOVO NORDISK : Receives a Buy rating from UBS 13/06 ZD
Novo Nordisk Surpasses SAP to Regain Europe's Most Valuable Listed Company Title 13/06 MT
Novo Nordisk regains crown as Europe's most valuable company 13/06 RE

Lars Fruergaard Jorgensen

Lars Fruergaard Jorgensen

Mr. Lars Fruergaard Jørgensen is a Vice President at European Federation of Pharmaceutical Industries & Assns, a Vice Chairman-Supervisory Board at Carlsberg A/S, a Member-Supervisory Board at Carlsberg Breweries A/S, a President & Chief Executive Officer at Novo Nordisk Ltd., a President & Chief Executive Officer at Novo Nordisk A/S and a Chairman at Harno Invest A/S. He is on the Board of Directors at Carlsberg A/S and Carlsberg Breweries A/S. Mr. Jørgensen was previously employed as a Member-Supervisory Board by Innate Pharma SA, a Vice President-Finance & Information Technology by Novo Nordisk Pharmaceutical SAS, and a Chairman by NNE Pharmaplan A/S. He also served on the board at ZymoGenetics, Inc. and NNIT A/S. He received his graduate degree from the University of Aarhus.

View full profile

Chart Novo Nordisk A/S

Chart Novo Nordisk A/S
NOVO B: Dynamic Chart

Company Profile

Logo Novo Nordisk A/S
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (93.6%); - rare disease treatment products (6.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (20.8%), the United States (57.6%), North America (3.7%), China (6.4%) and other (11.5%).
Employees
77,406
Sector
Pharmaceuticals
Calendar
21/06 - American Diabetes Association Scientific Conference - Oral Presentation: 86-OR
More about the company

Income Statement and Estimates

More financial data

Analysis / Opinion

The Parvus fund enters Novo Nordisk's capital

The Parvus fund enters Novo Nordisk's capital

10 June 2025 at 10:06 pm AEST

NOVO NORDISK : Acknowledging the intensifying competition

07 June 2025 at 01:40 am AEST

Wegovy on the rise amongst American teens; between effectiveness and reluctance

04 June 2025 at 07:03 pm AEST
Wegovy on the rise amongst American teens; between effectiveness and reluctance
More Strategies

Ratings

Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
482.50DKK
Average target price
662.91DKK
Spread / Average Target
+37.39%
Consensus
EPS Estimates
Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar
Indices Europe America Asia
More Indexes
My Watchlist
 

My lists
Rankings
 

More Top / Flop
Rankings
 

More Top / Flop

Currency / Forex

Forex

Commodities

Commodities

Cryptocurrencies

Cryptocurrencies
  1. Stock Market
  2. Equities
  3. NOVO B Stock
  4. News Novo Nordisk A/S
  5. Activist hedge fund Parvus builds stake in Novo Nordisk, FT reports
Best financial portal

Best financial
portal

+951% of historicalperformance

+951% of historical
performance

More than 20 yearsat your side

More than 20 years
at your side

Trustpilot
+ 1,000,000members

+ 1,000,000
members

Quick & easycancellation

Quick & easy
cancellation

Our Expertsare here for you

Our Experts
are here for you

Download from Apple Store

OUR EXPERTS ARE HERE FOR YOU

Monday - Friday 9am-12pm / 2pm-6pm GMT + 1

Contact us
MarketScreener, Stock Market Live
Legal information | Cookie settings | About us | Copyright © 2025 Surperformance SAS. All rights reserved.
Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
+89%* on our US portfolio vs. 52% on the S&P 500 net Total Return
Replicate our performance
Replicate our performance

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong